Tyme Technologies Inc (NASDAQ:TYME) Sellers Reduced Their Shorts By 18.24% As Of Jun 27, 2018

June 27, 2018 - By Ira Colvard

Tyme Technologies Inc (NASDAQ:TYME) had a decrease of its shorted shares by 18.24%. It was published in June by FINRA the 285,600 shorted shares on TYME. The 349,300 previous shares are down with 18.24%. 2 days will cost TYME with 163,500 average volume to recover its previous position. Float short on Tyme Technologies Inc is 1.14%.

The stock decreased 3.51% or $0.13 during the last trading session, hitting $3.57.Tyme Technologies, Inc. has volume of 43,085 shares. Since June 27, 2017 TYME has risen 3.14% and is uptrending. The stock underperformed the S&P500 by 9.43%.

Tyme Technologies, Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of cancer therapeutics for various oncology indications.The firm is worth $361.38 million. It is developing SM-88, a combination therapy in Phase II development for prostate cancer.Last it reported negative earnings.

More recent Tyme Technologies, Inc. (NASDAQ:TYME) news were announced by Nasdaq.com, Nasdaq.com and Globenewswire.com. The first one has “Tyme Appoints Pharma Executive Don DeGolyer to Board of Directors” as a title and was announced on May 30, 2018. The next is “Tyme Releases Detailed Data and Analyses with SM-88 From the First Human Study and Compassionate Use Programs” on June 12, 2018. And last was announced on June 25, 2018, called “Tyme Technologies, Inc. Set to Join Russell 3000® Index”.

Tyme Technologies, Inc. (NASDAQ:TYME) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.